ADMT · XBRL financial data

Adm Tronics Unlimited financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ADMT's year ends in late March)

In thousands of dollars	Q2 FY23Sep 30, 2023	Q3 FY23Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY24Sep 30, 2024	Q3 FY24Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY25Jun 30, 2025	Q2 FY25Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY26Jun 30, 2026
Cost of goods and services sold	548	375	488*	337	421	481	562*	492	512	531	457*	471
Gross profit	206	321	—	521	419	268	—	481	376	272	—	395
Research and development	132	178	137*	128	112	161	117*	126	97	180	142*	103
Selling, general and administrative	302	249	476*	229	353	196	194*	246	277	177	270*	312
Total operating expenses	434	427	613*	357	465	357	311*	372	373	357	412*	416
Operating income (loss)	(228)	(105)	(349)*	164	(46)	(89)	(123)*	109	3	(84)	(186)*	(21)
Interest income	7	6	5*	4	3	3	2*	2	1	3	2*	2
Interest expense	7	5	13*	8	9	8	15*	8	8	7	14*	7
Income tax expense (benefit)	0	0	0*	1	1	1	1*	2	0	0	0*	2
Net income (loss)	(228)	(105)	(412)*	272	(53)	(238)	(105)*	328	(115)	(115)	(198)*	32
Earnings per share, basic USD per share	0.00	0.00	(0.01)*	0.00	0.00	0.00	0.00*	0.00	0.00	0.00	0.00*	0.00
Earnings per share, diluted USD per share	—	—	—	—	—	0.00	—	—	—	0.00	—	—
Weighted average shares, basic thousands of shares	67,588	67,588	67,588*	67,588	67,588	67,588	67,588*	67,588	67,588	67,588	67,588*	67,588

Fiscal quarters (ADMT's year ends in late March)

In thousands of dollars	Q2 FY23Sep 30, 2023	Q3 FY23Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY24Sep 30, 2024	Q3 FY24Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY25Jun 30, 2025	Q2 FY25Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY26Jun 30, 2026
Cash and cash equivalents	716	662	537	469	428	431	383	370	321	299	256	223
Accounts receivable	—	—	345	504	467	374	528	557	552	560	516	604
Inventory	397	487	313	431	459	445	336	389	368	341	251	347
Prepaid and other current assets	24	8	19	19	13	6	2	11	6	0	0	12
Total current assets	2,011	1,938	1,214	1,424	1,366	1,256	1,249	1,327	1,247	1,200	1,022	1,185
Right-of-use asset	441	420	400	378	357	335	313	291	268	245	222	199
Total assets	2,742	2,615	2,139	2,508	2,407	2,148	2,128	2,388	2,160	2,052	1,827	2,023
Accounts payable	282	293	266	307	301	274	299	343	308	276	251	470
Accrued liabilities	77	101	61	69	21	57	29	49	20	83	54	92
Total current liabilities	1,169	1,168	1,124	1,108	1,041	1,042	1,149	1,108	1,018	1,057	1,046	1,235
Lease liability, non-current	366	344	322	298	275	252	228	205	182	155	130	104
Total liabilities	1,535	1,512	1,446	1,487	1,395	1,373	1,457	1,393	1,280	1,290	1,256	1,419
Accumulated deficit	(32,428)	(32,533)	(32,945)	(32,618)	(32,628)	(32,865)	(32,970)	(32,646)	(32,761)	(32,880)	(33,071)	(33,038)
Total stockholders' equity	1,207	1,103	692	1,020	1,012	775	671	995	880	761	571	603
Total liabilities and equity	2,742	2,615	2,139	2,508	2,407	2,148	2,128	2,388	2,160	2,052	1,827	2,023
Common shares outstanding (cover page) thousands of shares	67,588	67,589	67,588	67,588	67,588	67,588	67,588	67,588	67,588	67,588	67,588	67,588

Fiscal quarters (ADMT's year ends in late March)

In thousands of dollars	Q2 FY23Sep 30, 2023	Q3 FY23Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY24Sep 30, 2024	Q3 FY24Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY25Jun 30, 2025	Q2 FY25Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY26Jun 30, 2026
Net income (loss)	(228)	(105)	(412)*	272	(53)	(238)	(105)*	328	(115)	(115)	(198)*	32
Stock-based compensation	1*	1*	1*	1	1*	1*	1*	0	0*	0*	0*	—
Depreciation and amortization	1*	2*	2*	2	2*	1*	2*	2	2*	2*	2*	2
Net cash from operating activities	(203)*	(40)*	(215)*	(59)	(379)*	(73)*	521*	(15)	(63)	(20)*	(41)*	(33)
Net cash from investing activities	0*	(15)*	0*	0	339*	0*	(564)*	0	0*	0*	0*	0
Net cash from financing activities	74*	(0)*	90*	(9)	(1)*	76*	(4)*	2	(0)*	(3)*	(2)*	(0)
Net change in cash	(128)*	(54)*	(125)*	(68)	(42)*	3*	(48)*	(13)	(49)*	(22)*	(43)*	(33)

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Adm Tronics Unlimited	223	not reported	(33)	67.6M	6.8 quarters	Q1 FY26 10-QJun 30, 2026
Sonoma Pharmaceuticals	5,338	6,406	(649)	4.8M	8.2 quarters	Q1 FY27 10-QJun 30, 2026
Bone Biologics	6,088	not reported	(532)*	3.4M	9.8 quarters	Q3 FY26 10-QSep 30, 2026
Autonomix Medical	3,460	0	(3,544)	971,043	1.0 quarters	Q1 FY27 10-QJun 30, 2026
ENvue Medical	1,084	239	(2,691)*	11.1M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
SeaStar Medical Holding	6,959	615	(2,994)*	4.4M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Tenon Medical	1,677	1,279	(2,758)*	667,047	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Odyssey Health	122	not reported	(160)*	110.2M	0.8 quarters	Q4 FY26 10-KJul 31, 2026
Sintx Technologies	3,590	452	(2,767)*	6.7M	1.3 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.